Is Aptorum Group Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Aptorum Group Ltd (APM) is currently classified as NOT HALAL as of September 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Aptorum Group Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aptorum Group Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Aptorum Group Ltd?

Muslim investors may consider investing in Aptorum Group Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Aptorum Group Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Aptorum Group Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Aptorum Group Ltd updated?

The Shariah compliance status of Aptorum Group Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Aptorum Group Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Aptorum Group Ltd?

You can check the latest Shariah compliance status of Aptorum Group Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

APM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: September 17, 2025

Report Source: 2025 2nd Quarter Report

Aptorum Group Ltd. Stock Analysis APM

United States Health Care Nano Cap Report: Q2, 2025

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Key Statistics of Aptorum Group Ltd (APM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.81$0.91

Today's Open

$0.83

Volume

9271.00

P/E Ratio (TTM)

52 Week Range

$0.65$4.47

Market Cap

7.08M

Avg. Volume

20.65K

Dividend Yield

Financial Metrics & Statements of Aptorum Group Ltd (APM)

FAQ's for Aptorum Group Ltd (APM)

According to Musaffa’s Shariah screening methodology, Aptorum Group Ltd (APM) is currently classified as NOT HALAL as of September 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.